Antonio Omuro, MD
Neurology · Stanford, CANPI 1912175134
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,500 of the $18,338 with a category attached, or 62.7%. 3 manufacturers reported payments, led by Merck at 50.9% of the total. Reporting peaked in 2020 at $7,150 and has fallen 65.0% since, to $2,500 in 2024.
Across 15 payments — averaging $1222.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$9K
- BTG International Inc.$6K
- Telix Pharmaceuticals$3K
Across 89 payments — averaging $2928.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$95K
- Servier Bioinnovation$79K
- Incyte Corporation$42K
- Servier Pharmaceuticals LLC$25K
- Agios Pharmaceuticals, Inc.$19K
What the payments were for
- Consulting fees$11,50063%
- Speaking & faculty fees$5,37529%
- Travel & lodging$1,0015%
- Food & beverage$4623%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 8 | $9,343 |
| BTG International Inc. | 6 | $6,495 |
| Telix Pharmaceuticals | 1 | $2,500 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,338 in reported general payments places this provider in the 85th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Stanford
- Jeffrey DunnStanford$437K
- Neelam GoyalStanford$270K
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.